会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 65. 发明授权
    • Enhanced visibility materials for implantation in hard tissue
    • 增强植入硬组织的可见性材料
    • US07510579B2
    • 2009-03-31
    • US09828539
    • 2001-04-05
    • Howard Preissman
    • Howard Preissman
    • A61F2/02A61F2/04
    • A61B17/7095A61F2/28A61F2/30965A61F2/44A61F2/4601A61F2002/3008A61F2250/0098A61F2310/00293A61F2310/00329A61F2310/00353A61L24/001A61L27/50
    • An enhanced visibility composition for implantation from a remote source, so that the composition can be readily observed under fluoroscopy or other imaging techniques is disclosed. The compositions include a biocompatible matrix, such as a hard tissue implant material for example, and radiopaque particles mixed in the matrix. The radiopaque particles have a particle size between about 120μ and 2200μ, more preferably bout 350μ and 2200μ, even more preferably between about 450μ and 1600μ, and most preferably between about 570μ and 1150μ. Preferably the hard tissue implant and the radiopaque particles are formed or prepared in a slurry. Optionally, the enhanced visibility composition may further include additional radiopaque particles or contrast particles mixed in with the composition, which have a particle size between about 120μ and 350μ, preferably between about 120μ and 250μ.
    • 提供了用于从远程源植入的增强的可见性组合物,使得可以在荧光透视或其它成像技术下容易地观察组合物。 组合物包括生物相容性基质,例如硬组织植入材料和混入基质中的不透射线颗粒。 不透射线的颗粒的粒径为约120μm至2200μm,更优选为350μm和2200μm,甚至更优选为约450μm至1600μm,最优选为约570μm至1150μm。 优选地,硬组织植入物和不透射线的颗粒在浆液中形成或制备。 任选地,增强的可见性组合物可进一步包括与组合物混合的附加的不透射线颗粒或造影剂颗粒,其具有约120μm至350μm之间,优选约120μm至250μm的粒度。
    • 69. 发明申请
    • SYSTEMS FOR TREATING BONE
    • 治疗骨骼的系统
    • US20070233250A1
    • 2007-10-04
    • US11672434
    • 2007-02-07
    • John Shadduck
    • John Shadduck
    • A61F2/44
    • A61B17/7095A61B18/02A61B18/08A61B18/1206A61B2017/564
    • The present invention relates in certain embodiments to medical devices for treating vertebral compression fractures. In one embodiment, the invention relate to systems for introducing fill material into a vertebral body that slowly expands vertebral height without explosive balloon expansion as in kyphoplasty. The system provides a fill material that infills a vertebra without flowable bone cement as used in kyphoplasty and vertebropalsty procedures. Thus, the bone fill system prevents the possibility of extravasation of material into the spinal canal which occurs in a significant number of kyphoplasty and vertebropalsty procedures. An energy source can apply energy to a substantially rigid implant material in order to soften, melt, or fracture the implant material to infill a vertebral body.
    • 本发明在某些实施例中涉及用于治疗脊椎压缩性骨折的医疗装置。 在一个实施例中,本发明涉及用于将填充材料引入椎体中的系统,该椎体缓慢地扩大脊椎高度而没有爆炸性气囊膨胀,如在椎体后凸成形术中。 该系统提供填充椎体的填充材料,不需要可流动的骨水泥,如在脊柱后凸成形术和椎板植入术中使用的。 因此,骨填充系统防止材料外渗到脊柱管中的可能性,其发生在大量的脊柱后凸成形术和椎间盘手术中。 能量源可以将能量施加到基本上刚性的植入材料上,以便软化,熔化或折断植入材料以填充椎体。
    • 70. 发明申请
    • Enhanced visibility materials for implantation in hard tissue
    • 增强植入硬组织的可见性材料
    • US20070191964A1
    • 2007-08-16
    • US11246967
    • 2005-10-07
    • Howard Preissman
    • Howard Preissman
    • A61F2/28A61B6/12
    • A61L24/001A61B17/7095A61F2/28A61F2/30965A61F2/44A61F2/4601A61F2002/3008A61F2250/0098A61F2310/00293A61F2310/00329A61F2310/00353A61L27/50
    • An enhanced visibility composition for implantation from a remote source, so that the composition can be readily observed under fluoroscopy or other imaging techniques is disclosed. The compositions include a biocompatible matrix, such as a hard tissue implant material for example, and radiopaque tracer particles mixed in the matrix. The radiopaque tracer particles have a particle size between about 120μ and 2200μ, more preferably about 350μ and 2200μ, even more preferably between about 450μ and 1600μ, and most preferably between about 570μ and 1150μ. Preferably the hard tissue implant and the radiopaque tracer particles are formed or prepared in a slurry. Optionally, the enhanced visibility composition may further include additional radiopaque contrast particles mixed in with the composition, which have a particle size between about 120μ and 350μ, preferably between about 120μ and 250μ.
    • 提供了用于从远程源植入的增强的可见性组合物,使得可以在荧光透视或其它成像技术下容易地观察组合物。 组合物包括生物相容性基质,例如硬组织植入材料,以及混合在基质中的不透射线示踪剂颗粒。 不透射线的示踪剂颗粒具有约120μm至2200μm之间的粒径,更优选约350μm和2200μm,甚至更优选约450μm至1600μm,最优选约570μm至1150μm。 优选地,硬组织植入物和不透射线的示踪剂颗粒在浆液中形成或制备。 任选地,增强的可见性组合物还可以包括与组合物混合的附加的不透射线造影剂颗粒,其具有在约120μm至350μm之间,优选约120μm和250μm之间的粒度。